Showing results (41-50 of 422) with videos related to

Sort By:
Pageof 43
Cancer Research|January 6, 2026
Optimizing In Vivo CAR-T Cell Engineering for Cancer ImmunotherapyRuiheng Wang, Jianhua Yu, Michael A Caligiuri, et al.
The Journal of Clinical Investigation|October 25, 2016
MicroRNA-29b mediates altered innate immune development in acute leukemiaBethany L Mundy-Bosse, Steven D Scoville, Li Chen, et al.
Familial Cancer|May 8, 2026
Biallelic germline MBD4 mutations predispose to colorectal polyposis, hypermutated AML, and schwannomasJulia Cooper, Brittany L Stewart, Lauren Bokovitz, et al.
Blood|March 26, 2016
Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsSumithira Vasu, Shun He, Carolyn Cheney, et al.
Blood|April 29, 2025
High Incidence of Severe TA-TMA Increases Mortality in adult Allogeneic Transplant recipients: A prospective MIDAS Consortium studySumithira Vasu, Qiuhong Zhao, Elizabeth Greer Miller, et al.
Clinical Pharmacology and Therapeutics|March 24, 2018
Patient Enrichment for Precision-Based Cancer Clinical Trials: Using Prospective Cohort Surveillance as an Approach to Improve Clinical TrialsWilliam S Dalton, Daniel Sullivan, Jeffrey Ecsedy, et al.
European Journal of Immunology|June 1, 2013
Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell developmentIl-Kyoo Park, Rossana Trotta, Jianhua Yu, et al.
Leukemia & Lymphoma|October 12, 2024
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapiesJean Caputo, Ayush Peddireddi, Subodh Bhatta, et al.
Cytotherapy|April 19, 2020
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemiaRajeswaran Mani, Girish Rajgolikar, Jessica Nunes, et al.
Cancer Research|March 13, 2002
Cellular localization and function of Fas ligand (CD95L) in tumorsMasayuki Kurooka, Gerard J Nuovo, Michael A Caligiuri, et al.
Pageof 43